Ocular lymphoproliferative disorders

被引:0
作者
Moussa, Kareem [1 ]
Everett, Lesley [2 ]
机构
[1] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA
[2] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA
关键词
biopsy; lymphoid hyperplasia; lymphoma; REACTIVE LYMPHOID HYPERPLASIA; PRIMARY VITREORETINAL LYMPHOMA; CLINICAL-FEATURES; ASSOCIATION;
D O I
10.1097/ICU.0000000000000796
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review Ocular lymphoproliferative disorders are a heterogenous group of pathologic disorders with significant impact on quality of life and, at times, may be life-threatening. Due to the rarity of these disorders, information regarding proper diagnosis, treatment, and prognosis is limited. This review summarizes the key features of the unique diseases within this group of lymphoproliferative disorders, with a focus on disease presentation, diagnostic considerations, and treatment and prognosis. Recent findings High-quality data from recent studies have provided answers regarding clinical outcomes for subsets of ocular lymphoproliferative disorders and are included herein. New diagnostic techniques are also discussed as well as current treatment strategies. Ocular lymphoproliferative disorders are a rare group of diseases. Key features of each disease is presented in this review in a concise and readable format, as well as updated information regarding diagnostic considerations and treatment options.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 35 条
[1]   Benign reactive lymphoid hyperplasia of the conjunctiva in childhood [J].
AlAkeely, Adel G. ;
Alkatan, Hind M. ;
Alsuhaibani, Adel H. ;
AlKhalidi, Hisham ;
Abu Safieh, Leen ;
Coupland, Sarah E. ;
Edward, Deepak P. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (07) :933-939
[2]   More Than a Masquerade Syndrome: Atypical Presentations of Vitreoretinal Lymphomas [J].
AlQahtani, Abdullah ;
Touitou, Valerie ;
Cassoux, N. ;
Aknin, Cedric ;
Merle-Beral, Helene ;
Bodaghi, Bahram ;
Phuc LeHoang .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2014, 22 (03) :189-196
[3]   Lymphoid hyperplasia of the orbit and ocular adnexa: A clinical pathologic review [J].
Andrew, Nicholas H. ;
Coupland, Sarah E. ;
Pirbhai, Adnan ;
Selva, Dinesh .
SURVEY OF OPHTHALMOLOGY, 2016, 61 (06) :778-790
[4]   Uveal Lymphoma: Clinical Features, Diagnostic Studies, Treatment Selection, and Outcomes [J].
Aronow, Mary E. ;
Portell, Craig A. ;
Sweetenham, John W. ;
Singh, Arun D. .
OPHTHALMOLOGY, 2014, 121 (01) :334-341
[5]   Ocular Adnexal Lymphoma: Assessment of a Tumor-Node-Metastasis Staging System [J].
Aronow, Mary E. ;
Portell, Craig A. ;
Rybicki, Lisa A. ;
Sweetenham, John W. ;
Singh, Arun D. .
OPHTHALMOLOGY, 2013, 120 (09) :1915-1919
[6]   Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium [J].
Chan, Chi-Chao ;
Rubenstein, James L. ;
Coupland, Sarah E. ;
Davis, Janet L. ;
Harbour, J. William ;
Johnston, Patrick B. ;
Cassoux, Nathalie ;
Touitou, Valerie ;
Smith, Justine R. ;
Batchelor, Tracy T. ;
Pulido, Jose S. .
ONCOLOGIST, 2011, 16 (11) :1589-1599
[7]   Echographic findings in benign reactive lymphoid hyperplasia of the choroid [J].
Chang, TS ;
Byrne, SF ;
Gass, JDM ;
Hughes, JR ;
Johnson, RN ;
Murray, TG .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (06) :669-675
[8]   Lymphoproliferative disorders of the ocular adnexa [J].
Cockerham, GC ;
Jakobiec, FA .
INTERNATIONAL OPHTHALMOLOGY CLINICS, 1997, 37 (04) :39-59
[9]   Re-valuation of "reactive lymphoid hyperplasia of the uvea" - An immunohistochemical and molecular analysis of 10 cases [J].
Cockerham, GC ;
Hidayat, AA ;
Bijwaard, KE ;
Sheng, ZM .
OPHTHALMOLOGY, 2000, 107 (01) :151-158
[10]   Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center [J].
Dalvin, Lauren A. ;
Lim, Li-Anne S. ;
Ancona-Lezama, David ;
Mazloumi, Mehdi ;
Chang, Michael ;
Porcu, Pierluigi ;
Martinez, Nina L. ;
Glass, Jon ;
Mashayekhi, Arman ;
Shields, Carol L. .
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2020, 9 (02) :110-116